Nurtec Financial Assistance Guide

The financial assistance guide below is for anyone who has been prescribed Nurtec ODT by their healthcare provider. Nurtec ODT is a CGRP inhibitors approved for the prevention of migraine in adults. If you or someone you know requires help with paying for treatment, review the details provided below to see if you qualify for the manufacturer’s financial assistance program.

question

Most insurance companies have added at least one or two CGRP inhibitors to the list of medicines they cover; however, patients still struggle to receive insurance approval for the prescribed CGRP inhibitor. Each pharmaceutical company is offering financial assistance programs to help cover and/or to help cover the cost of high copays. Each program is different and various programs exist to support patients with private, government-funded insurance, as well as the uninsured.

comment

To help patients understand each program, CHAMP created Financial Assistance Guides for all CGRP inhibitors. These guides are not produced or approved by the medication manufacturers. CHAMP is not endorsing the use of any CGRP inhibitor over another, nor promoting the use of this new class of preventive medications for everyone with migraine disease. Every patient needs to consult their healthcare provider to determine if CGRP inhibitors are right for you.

I Have Been Prescribed Nurtec.

Find your insurance coverage and see what Financial Assistance Programs exist to help.

Nurtec Basics

Brand NameNurtec
Biologic Namerimegepant
Pharmaceutical CompanyPfizer
WebsiteNurtec.com
Helpline1-866-222-4183 | Monday–Friday, 8:00 AM–8:00 PM ET
Dosing & AdministrationRecommended dosage for acute treatment of migraine: 75 mg taken orally, as needed.

The safety of using more than 18 doses in a 30-day period has not been established.

Recommended dosage for preventive treatment of episodic migraine: 75 mg taken orally every other day.

The maximum dose in a 24-hour period is 75 mg.
Indicationacute treatment of migraine with or without aura in adults

preventive treatment of episodic migraine in adults